Promotion of intestinal peristalsis by bifidobacterium spp. capable of hydrolysing sennosides in mice

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Matsumoto, Mitsuharu ^a   Ishige, Atsushi ^b   Yazawa, Yuka ^a   Kondo, Manami ^a   Muramatsu, Koji ^a   Watanabe, Kenji ^c  

^a Nishitama gun   (Japan)

^b YOKOHAMA COLLEGE OF PHARMACY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHARCOAL; KANAMYCIN; RHEIN ANTHRONE; SENNOSIDE; ANTHRACENE DERIVATIVE; ANTHRAQUINONE DERIVATIVE; LACTIC ACID; PROBIOTIC AGENT; SENNOSIDE A&B;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM PSEUDOCATENULATUM; CONTROLLED STUDY; CULTURE MEDIUM; DRUG HYDROLYSIS; FECES LEVEL; FEMALE; INTESTINE FLORA; INTESTINE MOTILITY; LACTIC ACID BACTERIUM; MALE; MICROBIAL DIVERSITY; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THIN LAYER CHROMATOGRAPHY; ANIMAL; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INTESTINE; METABOLISM; METHODOLOGY; MICROBIOLOGY; PATHOLOGY; PERISTALSIS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; BIFIDOBACTERIUM PSEUDOCATENULATUM; MUS;

ANIMALS; ANTHRACENES; ANTHRAQUINONES; BIFIDOBACTERIUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; FEMALE; HYDROLYSIS; INTESTINES; LACTIC ACID; MALE; MICE; PERISTALSIS; PROBIOTICS;

EID: 84857475755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031700     Document Type: Article

References (27)

1. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd, (1993) Functional constipation and outlet delay: a population-based study. Gastroenterology 105: 781-790.
2. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, et al. (1993) U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 38: 1569-1580.
3. Walter S, Hallbook O, Gotthard R, Bergmark M, Sjodahl R, (2002) A population-based study on bowel habits in a Swedish community: prevalence of faecal incontinence and constipation. Scand J Gastroenterol 37: 911-916.
4. Stewart WF, Liberman JN, Sandler RS, Woods MS, Stemhagen A, et al. (1999) Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 94: 3530-3540.
5. Wald A, Scarpignato C, Mueller-Lissner S, Kamm MA, Hinkel U, et al. (2008) A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther 28: 917-930.
6. Foxx-Orenstein AE, McNally MA, Odunsi ST, (2008) Update on constipation: one treatment does not fit all. Cleve Clin J Med 75: 813-824.
7. Ford AC, Suares NC, (2011) Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 60: 209-218.
8. Hardcastle JD, Wilkins JL, (1970) The action of sennosides and related compounds on human colon and rectum. Gut 11: 1038-1042.
9. Dreessen M, Eyssen H, Lemli J, (1981) The metabolism of sennosides A and B by the intestinal microflora: in vitro and in vivo studies on the rat and the mouse. J Pharm Pharmacol 33: 679-681.
10. Hardcastle JD, Wilkins JL, (1970) The action of sennosides and related compounds on human colon and rectum. Gut 11: 1038-1042.
11. Lemli J, Lemmens L, (1980) Metabolism of sennosides and rhein in the rat. Pharmacology 20 (Suppl 1): 50-57.
12. Lemli J, (1988) Metabolism of sennosides-an overview. Pharmacology 36 (Suppl 1): 126-128.
13. Akao T, Che QM, Kobashi K, Yang L, Hattori M, et al. (1994) Isolation of a human intestinal anaerobe, Bifidobacterium sp. strain SEN, capable of hydrolyzing sennosides to sennidins. Appl Environ Microbiol 60: 1041-1043.
14. Kobashi K, Nishimura T, Kusaka M, Hattori M, Namba T, (1980) Metabolism of sennosides by human intestinal bacteria. Planta Med 40: 225-236.
15. Hattori M, Kim G, Motoike S, Kobashi K, Namba T, (1982) Metabolism of sennosides by intestinal flora. Chem Pharm Bull (Tokyo) 30: 1338-1346.
16. Dreessen M, Lemli J, (1982) Qualitative and quantitative interactions between the sennosides and some human intestinal bacteria. Pharm Acta Helv 57: 350-352.
17. Matsumoto M, Imai T, Hironaka T, Kume H, Watanabe M, et al. (2001) Effect of yoghurt with Bifidobacterium lactis LKM512 in improving fecal microflora and defecation of healthy volunteers. J Intest Microbiol 14: 97-102 (in Japanese with English summary).
18. Kozaki M, Uchimura T, Okada S, (1992) Method of isolation and stock for lactic acid bacteria. In: Kozaki M, editors. Experimental manual of lactic acid bacteria Tokyo Asakusashoten pp. 6-20.
19. Zwaving JH, (1980) Recent developments in the analysis of anthraquinone derivatives. Pharmacology 20 (Suppl 1): 65-75.
20. Tada T, Yamamura S, Kuwano Y, Abo T, (1996) Level of myelopoiesis in the bone marrow is influenced by intestinal flora. Cell Immunol 173: 155-161.
21. Matsuki T, Watanabe K, Fujimoto J, Kado Y, Takada T, et al. (2004) Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 70: 167-173.
22. Matsumoto M, Sakamoto M, Benno Y, (2009) Dynamics of fecal microbiota in hospitalized elderly fed probiotic LKM512 yogurt. Microbiol Immunol 53: 421-432.
23. Matsumoto M, Ohishi H, Benno Y, (2004) H+-ATPase activity in Bifidobacterium with special reference to acid tolerance. Int J Food Microbiol 93: 109-113.
24. Matsumoto M, Tani H, Ono H, Ohishi H, Benno Y, (2002) Adhesive property of Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin. Curr Microbiol 44: 212-215.
25. Matsumoto M, Sakamoto M, Benno Y, (2009) Dynamics of fecal microbiota in hospitalized elderly fed probiotic LKM512 yogurt. Microbiol Immunol 53: 421-432.
26. Bartosch S, Fite A, Macfarlane GT, McMurdo ME, (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70: 3575-3581.
27. Hattori M, Namba T, Akao T, Kobashi K, (1988) Metabolism of sennosides by human intestinal bacteria. Pharmacology 36 (Suppl 1): 172-179.